Close

Aurinia Pharmaceuticals' (AUPH) Voclosporin Phase 2b AURA-LV Study Meets Primary Endpoint in Lupus Nephritis

Go back to Aurinia Pharmaceuticals' (AUPH) Voclosporin Phase 2b AURA-LV Study Meets Primary Endpoint in Lupus Nephritis